Introduction {#sec1}
============

Female germline stem cells (FGSCs) have been successfully isolated from postnatal mammal ovarian tissue,[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14] enabling researchers to further understand human oogenesis, treat infertility, and delay menopause.[@bib15] This also provides a novel strategy for preserving fertility. While several studies recently revealed the regulatory mechanisms underlying FGSC differentiation,[@bib3], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20] proliferation,[@bib4], [@bib21], [@bib22], [@bib23], [@bib24] and apoptosis,[@bib21], [@bib25] which are considered crucial for female fertility, other biological processes such as autophagy and its mechanism in FGSCs are largely unknown, and the use of small compounds may help us to understand them further.

Benzoxaboroles, which were synthesized and characterized by Torssell in 1957,[@bib26] have medical applications because 5-fluroben-zoxaborole (AN2690) can inhibit fungal protein synthesis by targeting leucyl-tRNA synthetase (LeuRS)[@bib27] and is a promising clinical treatment for onychomycosis.[@bib26] The wide application of benzoxaboroles in anti-viral,[@bib28] anti-bacterial,[@bib29] anti-inflammatory,[@bib30] anti-parasite,[@bib31] and anti-cancer[@bib32] treatments was shown in recent studies. For example, two benzoxaboroles, AN2728 and AN2898, underwent phase II clinical trials as treatments for atopic dermatitis and psoriasis, because of their anti-inflammatory characteristics.[@bib26] However, the cell biological function of benzoxaboroles was only studied in SKOV-3 cells, and the result has shown that ZCL-082, a derivative of benzoxaboroles, significantly inhibited the proliferation of human ovarian cancer SKOV-3 cells,[@bib32] suggesting that it probably induces cell autophagy or apoptosis. To date there have been no studies of the autophagy function of benzoxaboroles in cells.

Long non-coding RNAs (lncRNAs), which do not encode proteins, can recruit transcription factors and sponge microRNAs (miRNAs) to destabilize mRNA.[@bib33], [@bib34], [@bib35], [@bib36] This type of RNA has been found to widely regulate the proliferation, differentiation, apoptosis, and autophagy of stem cells as competing endogenous RNAs (ceRNAs).[@bib37], [@bib38], [@bib39], [@bib40] In our previous study, we determined that growth arrest-specific 5 (*GAS5*), a lncRNA, promoted proliferation and inhibited apoptosis of FGSCs *in vitro*;[@bib21] but, whether and how *GAS5* executes other FGSC functions (e.g., autophagy or differentiation) are unclear.

miRNAs, short non-coding RNAs of 22--23 nt in size, can act as sponges for lncRNAs and silence the expression of coding or non-coding genes in animals and plants.[@bib33] Further, they are involved in cell signal transduction pathways and protein-protein networks by changing the expressions of proteins.[@bib33], [@bib41] *MiR-21a*, which can be sponged by *GAS5*,[@bib42] has been reported to play an important regulatory role in cell apoptosis, differentiation, autophagy, and proliferation by suppressing the expression of coding genes, such as programmed cell death protein 4 (*PDCD4*).[@bib43], [@bib44], [@bib45], [@bib46]

In our study, we investigated how ZCL-082 affected the biological function of FGSCs *in vitro*, and we revealed that ZCL-082 induced the autophagy of FGSCs through the *GAS5*/*miR-21a* axis. The results suggested that ZCL-082 and the *GAS5*/*miR-21a* axis have critical roles in the autophagy of FGSCs. Our findings also provide new insights into reproductive disorders and the preservation of female fertility.

Results {#sec2}
=======

ZCL-082 Reduced the Number, Viability, and Proliferation of FGSCs {#sec2.1}
-----------------------------------------------------------------

To detect whether ZCL-082 affects FGSC proliferation, the cells were treated with various concentrations of ZCL-082 (0.125, 0.25, 0.5, 1, 2, 4, and 8 μM), and FGSCs per well were counted using a hemocytometer. As shown in [Figures 1](#fig1){ref-type="fig"}B and 1C, the number of cells was significantly reduced by treatment with 1--8 μM ZCL-082 compared with the control (DMSO). Cell counting kit-8 (CCK8) and 5-ethynyl-2′-deoxyuridine (EdU) assays were used to detect cell viability and proliferation, respectively. As shown in [Figures 1](#fig1){ref-type="fig"}D and 1E, cell viability was significantly lower following treatment with 1, 2, 4, and 8 μM ZCL-082 for 24 or 48 h compared with the control. The results of the EdU assays showed that the cell proliferation rate was significantly lower in cells treated for 48 h with ZCL-082 at 0.5, 1, 2, 4, and 8 μM ([Figure 1](#fig1){ref-type="fig"}F). Taken together, these results indicated that ZCL-082 reduced the number, viability, and proliferation of FGSCs *in vitro*.Figure 1ZCL-082 Reduced the Number, Viability, and Proliferation of FGSCs(A) Chemical structure of ZCL-082. (B) Morphology of FGSCs treated with various concentrations of ZCL-082 (i, control; ii, 0.125 μM; iii, 0.25 μM; iv, 0.5 μM; v, 1 μM; vi, 2 μM; vii, 4 μM; and viii, 8 μM). Scale bar, 50 μm. Control was DMSO. (C) Number of FGSCs per 35-mm plate at various concentrations of ZCL-082. Control was DMSO. (D and E) Fold change in cell viability under different concentrations was detected by CCK8 assay at 24 h (D) and 48 h (E). Control was DMSO. (F and G) Cell proliferation was detected by EdU assay at various concentrations of ZCL-082 (F) and their results were statistically significant (G) (i, control; ii, 0.125 μM; iii, 0.25 μM; iv, 0.5 μM; v, 1 μM; vi, 2 μM; vii, 4 μM; and viii, 8 μM). Control was DMSO. Scale bar, 50 μm. Values are presented as mean ± SEM of three biological replicates. \*p \< 0.05, \*\*p \< 0.01.

ZCL-082 Induced FGSC Apoptosis and Autophagy *In Vitro* {#sec2.2}
-------------------------------------------------------

Next, we investigated why viability declined in FGSCs. The expression of *SYCP3* and S*TRA8*, differentiation markers of FGSCs, was determined by RT-PCR; no significant difference was found between the control and ZCL-082-treated cells for 48 h ([Figure S1](#mmc1){ref-type="supplementary-material"}). The results suggested that ZCL-082 has no effect on FGSC differentiation. Next, we used flow cytometry to elucidate whether ZCL-082 induces the apoptosis of FGSCs. As shown in [Figures 2](#fig2){ref-type="fig"}A and 2B, ZCL-082 induced the apoptosis of FGSCs. Because of the close relationship between apoptosis and autophagy during cell death,[@bib47], [@bib48] we determined whether ZCL-082 induced autophagy in FGSCs. Western blotting revealed that the protein expression of light chain 3 beta 2 (LC3B-II) in FGSCs was significantly increased after treatment with ZCL-082 for 3 and 6 h ([Figures 2](#fig2){ref-type="fig"}C and 2D). Meanwhile, sequestosome-1 (SQSTM1) protein expression was significantly decreased ([Figures 2](#fig2){ref-type="fig"}C and 2D). Immunofluorescence staining showed that the number of LC3B puncta per cell was significantly increased in treated cells ([Figures 2](#fig2){ref-type="fig"}E and 2F). Taken together, these results suggested that ZCL-082 could induce the autophagy of FGSCs *in vitro*.Figure 2Autophagy Was Induced by ZCL-082 in FGSCs(A and B) Flow cytometry detected the apoptosis of FGSCs after being treated with ZCL-082. Apoptosis was detected by FACs with Annexin V-PI Apoptosis Kit (A) and statistics (B). Control was DMSO. (C and D) Differential expressions of LC3B-II and SQSTM1 after treatment with ZCL-082 for 3 and 6 h. (C) Western blot showing the relative expression levels of LC3B-II and SQSTM1. (D) Densitometry demonstrated differences in expression were statistically significant. Control was DMSO. (E and F) Immunofluorescence staining of LC3B-II after treatment with ZCL-082. (E) LC3B puncta (F) numbers were found to be statistically significant. Control was DMSO. Scale bar, 25 μm. Values are mean ± SEM of three biological replicates. \*p \< 0.05, \*\*p \< 0.01.

The Expressions of Several Autophagy-Related lncRNAs Were Changed in FGSCs after Treatment with ZCL-082 {#sec2.3}
-------------------------------------------------------------------------------------------------------

lncRNAs were reported to be involved in the process of cell autophagy in previous studies.[@bib49], [@bib50] To discuss the ceRNA regulatory mechanism underlying FGSC autophagy induced by ZCL-082, we first selected lncRNAs related to autophagy, and we detected their expressions in FGSCs after ZCL-082 treatment. qRT-PCR showed that the expression of *GAS5* was significantly decreased, while the expression levels of *RP4*, *PTENP1*, *ROR*, and *HOTAIR* were significantly increased ([Figure 3](#fig3){ref-type="fig"}A). Additionally, after treatment, the expressions of *MEG3* and *MALAT1* were not significantly changed ([Figure 3](#fig3){ref-type="fig"}A).Figure 3Expression Changes of Several Autophagy-Related lncRNAs in FGSCs following ZCL-082 Treatment(A) Fold changes in *GAS5*, *RP4*, *PTENP1*, *ROR*, *HOTAIR*, *MEG3*, and *MALAT1* expressions after ZCL-082 treatment. Control was DMSO. (B--E) Differential expressions of LC3B-II and SQSTM1 after infection with Lenti-*GAS5* and Lenti-sh*GAS5*. Representative blots following infection with Lenti-*GAS5* (B) and Lenti-sh*GAS5* (D) are shown. Relative protein expression levels of LC3B and SQSTM1 in Lenti-*GAS5*- (C) and Lenti-sh*GAS5*-infected FGSCs (E) are shown. Lenti-sh*GAS5*, lentivirus carrying *GAS5*-knockdown plasmid; Lenti-shNC, lentivirus carrying control plasmid; Lenti-*GAS5*, lentivirus carrying *GAS5*-overexpressing plasmid; Lenti-NC, lentivirus carrying control plasmid. Data are shown as mean ± SEM of three biological replicates. \*p \< 0.05, \*\*p \< 0.01.

*GAS5* Inhibited FGSC Autophagy *In Vitro* {#sec2.4}
------------------------------------------

In our previous study, although *GAS5* could promote the proliferation of FGSCs and inhibit their apoptosis,[@bib21] the function of *GAS5* in FGSC autophagy was not investigated. To define the function of *GAS5* in FGSC autophagy, FGSCs were infected with *GAS5*-knockdown or -overexpressing lentiviral particles. Western blotting demonstrated that LC3B-II protein expression was significantly increased and that of SQSTM1 was significantly decreased compared with the control (Lenti-negative control of shRNA \[shNC\]), when cells were infected with *GAS5*-knockdown lentivirus ([Figures 3](#fig3){ref-type="fig"}B and 3C). Furthermore, LC3B-II protein expression was significantly decreased and that of SQSTM1 was significantly increased compared with the control (Lenti-negative control \[NC\]), after infection with *GAS5-*overexpressing lentivirus ([Figures 3](#fig3){ref-type="fig"}D and 3E). These results indicated that *GAS5* could inhibit FGSC autophagy *in vitro*.

Overexpression of *GAS5* Rescued FGSC Autophagy Induced by ZCL-082 {#sec2.5}
------------------------------------------------------------------

Based on the above results, we wondered whether overexpression of *GAS5* protects FGSCs from ZCL-082-induced autophagy. We constructed three separate groups: treatment with ZCL-082 for 3 h in Lenti-*GAS5*-infected FGSCs (group ZCL-082 + *GAS5*), treatment with ZCL-082 for 3 h in Lenti-NC-infected FGSCs (group ZCL-082 + NC), and treatment with DMSO for 3 h in Lenti-NC-infected FGSCs (group DMSO + NC). After treatment, LC3B-II and SQSTM1 protein expressions in the different groups were detected by western blotting; LC3B-II expression in group ZCL-082 + *GAS5* was significantly lower than that in group ZCL-082 + NC. Moreover, the expression of SQSTM1 in group ZCL-082 + GAS5 was significantly higher than that in group ZCL-082 + NC ([Figures 4](#fig4){ref-type="fig"}A and 4B). These results indicated that GAS5 overexpression could rescue the autophagy of FGSCs induced by ZCL-082.Figure 4Autophagy in ZCL-082-Treated FGSCs Was Rescued by the Overexpression of *GAS5*(A and B) After infection with Lenti-*GAS5* or Lenti-NC, FGSCs were treated with ZCL-082 for 3 h. Protein expressions of LC3B-II and SQSTM1 were detected by western blotting (A), and the results were statistically significant (B). Lenti-sh*GAS5*, lentivirus carrying *GAS5*-knockdown plasmid; Lenti-*GAS5*, lentivirus carrying *GAS5*-overexpressing plasmid; Lenti-NC, lentivirus carrying control. Data are presented as mean ± SEM of three biological replicates. \*p \< 0.05, \*\*p \< 0.01.

*GAS5* Regulated Autophagy by Sponging miR-21a {#sec2.6}
----------------------------------------------

To further explore the ceRNA regulatory mechanism underlying FGSC autophagy induced by ZCL-082 through *GAS5*, we selected miRNAs (*miR-21a*, *miR-222*, and *miR-23a*) that were reported in previous studies to be sponged by *GAS5*.[@bib42], [@bib51] We first detected the expressions of these miRNAs in Lenti-*GAS5*-infected FGSCs and Lenti-knockdown of GAS5 (sh*GAS5*)-infected FGSCs. The qRT-PCR results showed that the expression of *mir-21a* was significantly decreased in Lenti-*GAS5*-infected FGSCs while it was significantly increased in Lenti-sh*GAS5*-infected FGSCs compared with the control (Lenti-NC and Lenti-shNC, respectively) ([Figure 5](#fig5){ref-type="fig"}A). The qRT-PCR results also showed that, in both Lenti-*GAS5*- and Lenti-sh*GAS5*-infected cells, *miR-222* expression was significantly lower than in the control and *miR-23a* expression was significantly higher than in the control ([Figure 5](#fig5){ref-type="fig"}A). Combined with previous research,[@bib42] these results suggested that *GAS5* could directly bind *miR-21a* to negatively regulate each other.Figure 5ZCL-082 Induced Autophagy of FGSCs via *GAS5* Sponging of *miR-21a*(A) Relative expressions of *miR-21a*, *miR-222*, and *miR-23a* in Lenti-*GAS5* and Lenti-sh*GAS5* FGSCs. (B and C) Protein expressions of LC3B-II and SQSTM1 were detected by western blotting (B) after transfection for 24 h with *miR-21a* mimics and NC in FGSCs. The results of differential blots (C) were statistically significant. *miR-21a* mimic-NC, negative control of *miR-21a* mimic. Data are mean ± SEM of three biological replicates. \*p \< 0.05, \*\*p \< 0.01.

Next, FGSCs were transfected with *miR-21a* mimics, and the expressions of LC3B-II and SQSTM1 were detected by western blotting to determine whether the overexpression of *miR-21a* can induce FGSC autophagy. The results showed that *miR-21a* expression significantly enhanced the expression of LC3B-II protein ([Figures 5](#fig5){ref-type="fig"}B and 5C) while significantly reducing the expression of SQSTM1 protein in FGSCs compared with control cells (*miR-21a* mimic-NC) ([Figures 5](#fig5){ref-type="fig"}D and 5E). These results revealed that *miR-21a* could promote FGSC autophagy.

ZCL-082 Induced the Autophagy of FGSCs through *miR-21a* {#sec2.7}
--------------------------------------------------------

The abovementioned results revealed that ZCL-082 downregulated the expression of *GAS5*. Additionally, *GAS5* could directly bind to *miR-21a*, which could promote FGSC autophagy. These conclusions suggest that ZCL-082-induced FGSC autophagy requires *miR-21a*. To test whether ZCL-082 induces the autophagy of FGSCs through *miR-21a*, FGSCs were transfected with a specific inhibitor of *miR-21a*. Western blotting showed that *miR-21a* inhibition significantly reduced basal and ZCL-082-induced LC3B-II protein expression while significantly enhancing the basal or ZCL-082-downregulated protein expression of SQSTM1 in FGSCs ([Figures 6](#fig6){ref-type="fig"}A and 6B). These data demonstrated that ZCL-082 induced the autophagy of FGSCs through *miR-21a*.Figure 6ZCL-082 Induced Autophagy of FGSCs via *miR-21a*(A and B) The expressions of LC3B-II and SQSTM1 in FGSCs were detected by western blotting. (A) After transfection for 24 h with *miR-21a*-specific inhibitor or NC, FGSCs were then treated with ZCL-082 or DMSO. The results of differential blots (B) were statistically significant. *miR-21a* IN, inhibitor of *miR-21a*; *miR-21a* IN-NC, negative control of inhibitor of *miR-21a*; *miR-21a* mimic-NC, negative control of *miR-21a* mimic. (C) *PDCD4* expression was detected by qRT-PCR, and the results were statistically significant. (D and E) *PDCD4* expression was detected by RT-PCR (D) and the results were statistically significant (E). (F and G) Protein expression of PDCD4 was detected after transfection for 24 h with *miR-21a* mimics and miR-21a IN in FGSCs (F). The results of differential blots (G) were statistically significant. (H and I) Protein expression of PDCD4 was detected by western blotting (H) after infection with Lenti-*GAS5* and Lenti-sh*GAS5*. The results were statistically significant (I). Lenti-sh*GAS5*, lentivirus carrying *GAS5*-knockdown plasmid; Lenti-shNC, lentivirus carrying control plasmid; Lenti-*GAS5*, lentivirus carrying *GAS5*-overexpressing plasmid; Lenti-NC, lentivirus carrying control plasmid. Data are mean ± SEM of three biological replicates. \*p \< 0.05, \*\*p \< 0.01.

Previous studies showed that *PDCD4* is a downstream target of *miR-21a* in other cell types and is closely related to autophagy.[@bib46], [@bib52], [@bib53] To confirm that *PDCD4* is a downstream target of *miR-21a* in FGSCs, the cells were transfected with *miR-21a* mimic and specific inhibitor of *miR-21a*. The western blot showed that the transfection of miR-21a showed that the transfection of *miR-21a* mimic significantly reduced the expression of PDCD4 compared with control *miR-21a* (mimic-NC). Conversely, the inhibition of *miR-21a* significantly enhanced the expression of PDCD4 compared with the control (*miR-21a* inhibitor-negative control \[IN-NC\]) ([Figures 6](#fig6){ref-type="fig"}C, 6D, 6F, and 6G). Furthermore, we detected the protein expression of PDCD4 in Lenti-*GAS5*-infected FGSCs and Lenti-sh*GAS5*-infected FGSCs. The results of western blot showed that the expression of PDCD4 was significantly decreased in Lenti-sh*GAS5*-infected FGSCs while it was significantly increased in Lenti-*GAS5*-infected FGSCs compared with the control (Lenti-NC and Lenti-shNC, respectively) ([Figures 6](#fig6){ref-type="fig"}H and 6I). These data showed that *PDCD4* was a downstream target of *miR-21a* in FGSCs and GAS5 was able to regulate PDCD4.

Discussion {#sec3}
==========

Since a previous study reported that AN2690 targets LeuRS to inhibit fungal infections,[@bib27] benzoxaboroles and their derivatives have garnered attention in recent years. With their low toxicity and physicochemical properties, benzoxaboroles are considered a promising anti-infective therapy.[@bib26], [@bib29] Our present study investigated for the first time the roles of ZCL-082 in regulating the proliferation, apoptosis, and autophagy of FGSCs *in vitro*. Moreover, this study revealed that ZCL-082 induced the autophagy of FGSCs through *GAS5* acting as a ceRNA sponge for *miR-21a*. These results may provide new insights for drug discovery and clinical treatment.

Premature ovarian failure (POF) is defined as menopause among women under 40 years of age who present with amenorrhea, hypergonadotropic hypogonadism, infertility, and other complicated disorders in the clinic.[@bib54] Genetic predisposition, enzymatic disease, autoimmune disease, and environmental factors are reported to lead to POF. Moreover, non-physiological inhibition of autophagy leads to POF.[@bib55] The clinical application of FGSCs is considered a novel strategy to preserve fertility in women.[@bib2], [@bib3] In addition, as one of the hallmarks of aging, autophagy affects the number and function of stem cells.[@bib56] Studies have shown that mesenchymal stem cells and hematopoietic stem cells lose their regenerative capacity when they reach an advanced age.[@bib57], [@bib58] In the aged stem cell population, autophagy is defective.[@bib56], [@bib57], [@bib58] Some studies have shown that stem cells required autophagy to clear away cellular waste.[@bib56] Many experiments have also confirmed the important role of autophagy in both cell survival and cell death.[@bib57], [@bib58] The function of stem cells requires correct autophagic activity, and pharmacological recovery of autophagy can act as a novel potential strategy to maintain stem cell activity for regenerative medicine and aging.[@bib56]

A few studies have shown that autophagy is a cell survival mechanism to maintain the development of female germ cells prior to establishing primordial follicle pools in the ovary.[@bib59], [@bib60] As stem cells in female germ cells, FGSCs have the capacity for self-renewal and differentiation to oocytes. It is significant for the treatment of POF to study the molecular mechanism of FGSC autophagy. In this study, we used compound ZCL-082 to induce FGSC autophagy, and we found that the GAS5/miR-21a axis was involved in the molecular mechanism of FGSC autophagy. Our results show that GAS5 and miR-21a are potential targets for the treatment of POF, by activating the appropriate autophagy level of FGSCs to protect cell survival or inhibiting excessive autophagy of FGSCs to prevent cell autophagic death.

*GAS5* recruits transcription factors during embryonic development for the regulation of cell growth, differentiation, and development.[@bib61], [@bib62] Additionally, *GAS5* was reported to be a tumor suppressor in several cancer cells.[@bib63], [@bib64] Previous work in our laboratory showed that *GAS5* promoted FGSC proliferation and inhibited FGSC apoptosis *in vitro*.[@bib21]

Recently, several studies showed that lncRNAs may function as ceRNA sponges of miRNAs.[@bib65], [@bib66] As a well-known onco-microRNA, *miR-21a* was sponged up by *GAS5* to induce the death of breast tumor cells *in vitro* and *in vivo*.[@bib42], [@bib67] In this study, we revealed that *GAS5* acts as a ceRNA by sponging *miR-21a* to inhibit autophagy in FGSCs.

In conclusion, autophagy in female germ cells is rarely studied, but our study revealed for the first time that the AN2690 analog ZCL-082 induces lower viability and autophagy of FGSCs through *GAS5*. In addition, we revealed a novel autophagic regulatory mechanism for FGSCs treated with ZCL-082 *in vitro* ([Figure 7](#fig7){ref-type="fig"}). We identified that ZCL-082 induced autophagy through the function of *GAS5* as a ceRNA sponge for *mir-21a* in FGSCs. Our study also suggested that the *GAS5*/*miR-21a* axis may be a potential therapeutic target for POF in the clinic. In further studies, we will focus on the effect of ZCL-082 on ovarian function *in vivo* and also the *GAS5*/*miR-21a* axis as a drug target for clinical application.Figure 7Proposed Model of *GAS5*/*miR-21a* Axis in the Regulation of ZCL-082-Induced AutophagyZCL-082 induces autophagy in FGSCs by regulating *GAS5*, which acts as a ceRNA sponge for *miR-21a*, thus modulating the expression of *PDCD4*.

Materials and Methods {#sec4}
=====================

Animals {#sec4.1}
-------

The 5-day-old mice were purchased from SLRC Laboratory (Shanghai, China). All animal procedures were approved by the Institutional Animal Care and Use Committee of Shanghai. The procedures were also performed in accordance with the National Research Council Guide for the Care and Use of Laboratory Animals.

Structure of Chemical Compound {#sec4.2}
------------------------------

ZCL-082 is a derivative of benzoxaboroles and its structure is shown in [Figure 1](#fig1){ref-type="fig"}.

FGSC Culture {#sec4.3}
------------

We established the FGSC line in a previous study.[@bib4] In brief, the cells were cultured in minimum essential medium alpha (MEM-alpha; Invitrogen Life Sciences, MA, USA), supplemented with 10% fetal bovine serum (FBS), 10 ng/mL mouse leukemia inhibitory factor (mLIF; Santa Cruz Biotechnology, CA, USA), 10 ng/mL mouse epidermal growth factor (mEGF; PeproTech, NJ, USA), 40 ng/mL mouse glial cell line-derived neurotrophic factor (mGDNF; R&D Systems, Minneapolis, MN, USA), 10 ng/mL mouse basic fibroblast growth factor (mbFGF; BD Biosciences, Franklin Lakes, NJ, USA), 10 mg/mL penicillin (Amresco, Lardner, PA, USA), 30 mg/mL pyruvate (Amresco, Lardner, PA, USA), β-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA), 1 mM non-essential amino acids (Invitrogen Life Sciences, MA, USA), and 2 mM L-glutamine (Amresco, Lardner, PA, USA).

Cells were cultured in SIM-6-thiogunaniaoualiain cells (STOs) as a feeder line, and cells were passaged every 5 days. Cells were infected with lentivirus carrying *GAS5* knockdown plasmid, *GAS5* overexpression plasmid, or control plasmid, as previously described.[@bib21] Cells were also transfected with inhibitor or mimic of *miR-21a* (Ribobio, Guangzhou, China) using Lipofectamine 3000 (Thermo Fisher Scientific, MA, USA), according to the manufacturer's instructions.

CCK8 Assay {#sec4.4}
----------

Cells were seeded at a density of 5,000 cells/well in a 96-well plate and cultured overnight. After treatment with ZCL-082 for 24 and 48 h, 100 μL CCK8, diluted 1:100 in cell culture medium, was added per well and incubated for 1 h at 37°C before the optical density (OD) value was detected at 450 nm, using a microplate spectrophotometer (Bio-Tek Instruments, Thermo Fisher Scientific, Winooski, VT, USA).

EdU Assay {#sec4.5}
---------

When the cells had reached 80% confluency, they were treated with ZCL-082 for 48 h and incubated with 50 mM EdU for 2 h. Then the cells were fixed in 4% paraformaldehyde and stained with Apollo Dye Solution and Hoechst 33342. Images were obtained with a Leica microscope (Leica, Wetzlar, Germany), and the number of EdU-positive cells was counted.

RT-PCR and Real-Time qRT-PCR {#sec4.6}
----------------------------

Trizol reagent (QIAGEN, Hilden, Germany) was used to extract total RNA. Approximately 1,000 ng RNA was reverse transcribed to cDNA using a reverse transcription kit (Takara, Tokyo, Japan). Then we used an ABI 7500 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA) to detect the expression levels of mRNA, lncRNA, and miRNA. The PCR reaction conditions were as follows: 94°C for 10 min; followed by 94°C for 5 s, 58°C for 30 s, and 72°C for 10 s for 35 cycles; and then 72°C for 10 min. All experiments were repeated three times. Expression was analyzed by applying the 2^−ΔΔCt^ method. Primers are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

Western Blotting {#sec4.7}
----------------

Cells were lysed in radio immunoprecipitation assay (RIPA) buffer (Yeasen, Shanghai, China), and protein was collected by centrifugation (4°C, 12,000 × *g*, 10 min). Protein concentrations were determined by bicinchoninic acid (BCA) protein assay kit (Yeasen, Shanghai, China). Proteins were separated by 15% SDS-PAGE and subsequently transferred onto polyvinylidene fluoride (PVDF) membranes. Membranes were blocked with 5% non-fat milk in Tris-buffered saline Tween 20 (TBST) for 2 h with gentle shaking at room temperature, then incubated overnight with the following primary antibodies: anti-LC3B (1:1,000; Abcam, Cambridge, MA, USA), anti-SQSTM1 (1:1,000; Abcam, Cambridge, MA, USA), anti-PDCD4 (1:1,000; Abcam, Cambridge, MA, USA), and anti-β-tubulin (1:6,000; Abcam, Cambridge, MA, USA). The membranes were washed three times with TBST for 10 min and incubated for 1 h with secondary antibodies (1:2,000, Proteintech, Rosemont, IL, USA) at room temperature. Protein bands were scanned using a Tanon 4600SF (Tanon, Shanghai, China). The density of protein bands was quantified with Image-Pro Plus 6.0 software, and the ratio of target protein to β-tubulin, which reflects the changes in expression levels, was calculated.

Cell Immunofluorescence Assay {#sec4.8}
-----------------------------

The cells were fixed in 4% paraformaldehyde and washed twice with 3% BSA. Then cells were treated with 0.5% Triton X-100 for 15 min at room temperature and washed twice with 3% BSA. Using 10% goat serum in BSA, cells were blocked for 1 h at room temperature. Cells were incubated with an anti-LC3B antibody in BSA (1:150; Abcam, Cambridge, MA, USA) overnight at 4°C. After incubation, cells were washed twice with PBS and incubated with fluorescent secondary antibodies in PBS at room temperature for 1 h (1:250; Proteintech, Wuhan, China). Then the cells were washed twice with PBS and stained with DAPI at room temperature for 5 min. Finally, the cells were washed twice with PBS, and images were obtained with a Leica XP8 fluorescence confocal microscope (Leica, Wetzlar, Germany).

Apoptosis Analysis {#sec4.9}
------------------

FGSCs were treated with ZCL-082 for 48 h. Then annexin V-propidium iodide (PI) (Thermo Fisher Scientific, MA, USA) was used to detect apoptotic cells. In brief, cells were collected and washed with 1× binding buffer and incubated with annexin V and PI for 20 min at room temperature in the dark. Finally, apoptotic cells were detected by flow cytometry (FACSCalibur, BD Biosciences, NJ, USA).

Statistical Analyses {#sec4.10}
--------------------

All experiments were replicated at least three times. The data are presented as mean ± SEM. Student's t test was performed with SPSS software; p values \<0.05 were considered statistically significant.
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